신장신경차단술 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Renal Denervation Market size is expected to reach USD 19.48 Million in 2034 from USD 0.88 Million (2025) growing at a CAGR of 41.16% during 2026-2034.

The global renal denervation market is gaining momentum as a promising treatment option for resistant hypertension. This minimally invasive procedure targets overactive nerves in the renal arteries, helping to reduce blood pressure in patients who do not respond well to medication. Increasing prevalence of hypertension and cardiovascular diseases has significantly contributed to market growth.

Key drivers include advancements in catheter-based technologies and growing clinical evidence supporting the effectiveness of renal denervation procedures. Rising awareness among healthcare professionals and patients has also boosted adoption. Additionally, the increasing burden of lifestyle-related diseases, such as obesity and diabetes, has created a strong demand for alternative treatment solutions.

In the coming years, the market is expected to expand with ongoing clinical trials and technological innovations. Improved device designs and enhanced procedural safety will drive adoption rates. As healthcare systems focus on preventive care and minimally invasive treatments, renal denervation is likely to become an important component of hypertension management strategies worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Symplicity
• Enlightn
• Vessix
• Paradise
• Iberis
• Others

By Technology

• Radiofrequency
• Ultrasound
• Micro-Infusion

By End User

• Hospitals
• Specialty Clinics
• Others

COMPANIES PROFILED

• Boston Scientific Corporation, Cardiosonic Ltd, Johnson Johnson, Medtronic plc, Ablative Solutions Inc, Terumo Corporation, Mercator MedSystems Inc, ReCor Medical Inc, Renal Dynamics Limited, Abbott Laboratories
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL RENAL DENERVATION MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Symplicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Enlightn Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Vessix Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Paradise Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Iberis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RENAL DENERVATION MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Radiofrequency Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Ultrasound Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Micro-Infusion Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RENAL DENERVATION MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL RENAL DENERVATION MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Technology
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Technology
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Technology
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Technology
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Technology
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL RENAL DENERVATION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Boston Scientific Corporation
  • 9.2.2 Cardiosonic Ltd
  • 9.2.3 Johnson & Johnson
  • 9.2.4 Medtronic Plc
  • 9.2.5 Ablative Solutions Inc
  • 9.2.6 Terumo Corporation
  • 9.2.7 Mercator MedSystems Inc
  • 9.2.8 ReCor Medical Inc
  • 9.2.9 Renal Dynamics Limited
  • 9.2.10 Abbott Laboratories